California Public Employees Retirement System
PRVL

California Public Employees Retirement System’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

California Public Employees Retirement System’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-32,305
Closed -$745K – 3564
2020
Q4 		$745K Sell
32,305
-600
-2% -$7.6K ﹤0.01% 2673
2020
Q3 		$335K Buy
32,905
+1,300
+4% +$17.4K ﹤0.01% 3033
2020
Q2 		$471K Buy
+31,605
New +$487K ﹤0.01% 2721

California Public Employees Retirement System's PRVL Position: Q1 2021 in Review

California Public Employees Retirement System sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 32,305 shares — an estimated $745K sold.

California Public Employees Retirement System first reported a position in PRVL in Q2 2020 and held it in 3 quarters. The position peaked at $745K in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

  • California Public Employees Retirement System reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 32,305 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $745K.
  • California Public Employees Retirement System first reported a position in Prevail Therapeutics Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • California Public Employees Retirement System's Prevail Therapeutics Inc. Common Stock position peaked at $745K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on California Public Employees Retirement System's 13F filing for Q1 2021, filed 14 May 2021.